A Single Measure of Cancer Burden in Korea from 1999 to 2010

Cho, Kyoung Hee; Park, Sohee; Lee, Kwang-Sig; Jang, Sung In; Yoo, Keunje; Kim, Jae Hyun; Park, Sohee

doi:10.7314/apjcp.2013.14.9.5249

Cited by 14 publications

(13 citation statements)

References 13 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Lung cancer is the leading cause for tumor-associated deaths, in which non-small cell lung cancer (NSCLC) accounts for 85% and most patients are in advanced stages with poor therapeutic efficacy when diagnosed (Jemal et al, 2010;Cho et al,2013;Lu et al, 2013;Yan et al, 2013;Kim et al, 2014). Though there has been great development in clinical treatment of NSCLC, its prognosis is still unsatisfactory due to the low rate of 5-year survival in clinic (Verdecchia et al, 2007).…”

Section: Introductionmentioning

confidence: 99%

Effect of Withaferin A on A549 Cellular Proliferation and Apoptosis in Non-small Cell Lung Cancer

Cai¹,

Sheng²,

Chen³

et al. 2014

Asian Pacific Journal of Cancer Prevention

View full text Add to dashboard Cite

Section: Introductionmentioning

confidence: 99%

Effect of Withaferin A on A549 Cellular Proliferation and Apoptosis in Non-small Cell Lung Cancer

Cai¹,

Sheng²,

Chen³

et al. 2014

Asian Pacific Journal of Cancer Prevention

View full text Add to dashboard Cite

“…Increased research on patients with cancer has led to significant developments in its treatment and management . Despite this progress, cancer remains the disease with the heaviest financial burden and highest mortality in Korea (Cho et al, 2013). As the survival period of cancer patients increases and treatment methods become increasingly diversified, treatment of critically ill cancer patients has become an important factor in their prognosis (Wigmore et al, 2013).…”

Section: Introductionmentioning

confidence: 99%

Factors Influencing Ventilator-Associated Pneumonia in Cancer Patients

Park

Cho²,

Kwak³

2014

Asian Pacific Journal of Cancer Prevention

View full text Add to dashboard Cite

Background: With increasing survival periods and diversification of treatment methods, treatment of critically ill cancer patients has become an important factor influencing patient prognosis. Patients with cancer are at high risk of infections and subsequent complications. This study investigated the incidence and factors contributing to the development of ventilator-associated pneumonia (VAP). Materials and Methods: This retrospective study investigated the incidence of VAP and factors leading to infection in patients admitted to the intensive care unit (ICU) of a cancer center from January 1, 2012 to December 31, 2013. Results: The incidence of VAP was 2.13 cases per 1,000 days of intubation, and 13 of 288 patients (4.5%) developed VAP. Lung cancer was the most common cancer associated with VAP (N=7, 53.9%), and longer hospital stays and intubation were associated with increased VAP incidence. In the group using a "ventilator bundle," the incidence was 1.14 cases per 1,000 days compared to 2.89 cases per 1,000 days without its use; however, this difference was not statistically significant (p=0. The incidence of pneumonia among critically ill cancer patients is highest in those with lung cancer, but lower than among non-cancer patients. The length of hospital stay and time on mechanical ventilation are important risk factors for development of VAP. Although not statistically significant, "ventilator bundle" care is an effective intervention that delays or reduces incidence of VAP. Major risk factors for VAP include age (≥ 65 years), surgery, and tracheostomy, while fungi, gram-negative bacteria, and multidrug-resistant organisms were identified as the major causative pathogens of VAP in this study.

show abstract

“…The study identified CS items and their medical record sources in registered cases of stomach cancer, which has one of the highest incidence and mortality rates in Korea (Leung et al, 2008;Seo et al, 2012;Cho et al, 2013;Jung et al, 2014).…”

Section: Methodsmentioning

confidence: 99%